BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 3308208)

  • 1. Opsonization of yeast by human serum IgA anti-mannan antibodies and phagocytosis by human polymorphonuclear leucocytes.
    Yeaman GR; Kerr MA
    Clin Exp Immunol; 1987 Apr; 68(1):200-8. PubMed ID: 3308208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of C3 levels on yeast opsonization by normal and pathological sera: identification of a complement independent opsonin.
    Kerr MA; Falconer JS; Bashey A; Beck JS
    Clin Exp Immunol; 1983 Dec; 54(3):793-800. PubMed ID: 6652976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphonuclear neutrophil iodination response as an estimate of defective yeast opsonization.
    Roberton DM; Dhanjal NK; Levinsky RJ; Mowbray JF; Turner MW
    Clin Exp Immunol; 1981 Jan; 43(1):208-14. PubMed ID: 7018758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired opsonization by serum from patients with chronic liver disease.
    Wyke RJ; Rajkovic IA; Williams R
    Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of the IgA receptor from human polymorphonuclear leucocytes.
    Albrechtsen M; Yeaman GR; Kerr MA
    Immunology; 1988 Jun; 64(2):201-5. PubMed ID: 3292406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suboptimal C3b/C3bi deposition and defective yeast opsonization. II. Partial purification and preliminary characterization of an opsonic co-factor able to correct sera with the defect.
    Turner MW; Seymour ND; Kazatchkine MD; Mowbray JF
    Clin Exp Immunol; 1985 Nov; 62(2):435-41. PubMed ID: 3910314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Opsonins in human serum for the phagocytosis of complexes between IgG and protein A of Staphylococcus aureus.
    Hällgren R; Stålenheim G
    Immunology; 1978 Jul; 35(1):13-20. PubMed ID: 680797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of C3b deposition on yeast surfaces by sera of known opsonic potential.
    Turner MW; Mowbray JF; Roberton DR
    Clin Exp Immunol; 1981 Nov; 46(2):412-9. PubMed ID: 7039889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of the serum defect in yeast opsonization in children with fulminant hepatic failure (FHF).
    Larcher VF; Wyke RJ; Mowat AP; Williams R
    Clin Exp Immunol; 1981 Nov; 46(2):406-11. PubMed ID: 7039888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kinetic studies of phagocytosis. III. The complement-dependent opsonic and anti-opsonic effects of normal and sle sera.
    Håkansson L; Hällgren R; Venge P
    Immunology; 1982 Sep; 47(1):91-9. PubMed ID: 6981589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The significance of immunofluorescent immunoglobulin inclusions in polymorphonuclear leucocytes for the detection of circulating immune complexes.
    Kauffmann RH; de Rooy-Dijk HH; Klein F; Lafeber GJ; Cats A; van Es LA
    Clin Exp Immunol; 1983 Oct; 54(1):203-12. PubMed ID: 6311469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum factors capable of opsonizing Shigella for phagocytosis by polymorphonuclear neutrophils.
    Reed WP
    Immunology; 1975 Jun; 28(6):1051-9. PubMed ID: 1132888
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defective serum opsonization activity in children aged 6-48 months having acute purulent otitis media.
    Tezcan I; Yilmaz Y; Oner F; Yel L; Sanal O; Ersoy F; Onerci M; Berkel AI
    Turk J Pediatr; 1997; 39(4):453-7. PubMed ID: 9433146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA- and secretory IgA-opsonized S. aureus induce a respiratory burst and phagocytosis by polymorphonuclear leucocytes.
    Gorter A; Hiemstra PS; Leijh PC; van der Sluys ME; van den Barselaar MT; van Es LA; Daha MR
    Immunology; 1987 Jul; 61(3):303-9. PubMed ID: 3610212
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Murine anti-lymphocyte monoclonal antibodies fail to act as opsonins for allogeneic human peripheral blood polymorphonuclear phagocytes.
    Roberton DM; Georgiou GM; Ellis WM; Hosking CS
    Clin Exp Immunol; 1984 Feb; 55(2):444-50. PubMed ID: 6199142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Defects in opsonization activity of the serum of patients with chronic arthritis].
    Böhm U; Merétey K; Seszták M; Hodinka L; Koó E; Zahumenszky Z
    Z Rheumatol; 1988; 47(3):161-5. PubMed ID: 3213263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of C3b/C3bi opsonization and chemiluminescence with selected yeasts and bacteria using sera of different opsonic potential.
    Turner MW; Grant C; Seymour ND; Harvey B; Levinsky RJ
    Immunology; 1986 May; 58(1):111-5. PubMed ID: 3519441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new semiquantitative radiometric opsonin assay. Selective measurement of opsonizing capacity of the alternative pathway.
    Yamamura M; Valdimarsson H
    Immunology; 1978 Apr; 34(4):689-94. PubMed ID: 363601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor affecting the in vitro assessment of opsonization: a study of the kinetics of opsonization using the technique of phagocytic chemiluminescence.
    Williams AJ; Hastings MJ; Easmon CS; Cole PJ
    Immunology; 1980 Dec; 41(4):903-11. PubMed ID: 7007217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.